Valuation: ChronoScale Holdings Corporation

Market Cap 2.64B 2.31B 2.12B 1.98B 3.75B 251B 3.81B 25.47B 9.9B 124B 9.91B 9.7B 426B P/E 2024 *
-
P/E 2025 -
Enterprise Value 2.86B 2.5B 2.3B 2.14B 4.06B 272B 4.12B 27.57B 10.72B 134B 10.73B 10.5B 461B EV / Sales 2024 *
-
EV / Sales 2025 2.71x
Free-Float
2.43%
Yield 2024 *
-
Yield 2025 -
1 day-11.91%
1 week-21.37%
Current month-26.54%
1 month-14.42%
3 months+273.96%
6 months+273.96%
Current year+273.96%
1 week 15.97
Extreme 15.97
23.55
1 month 15.8
Extreme 15.8
28.14
Current year 8.71
Extreme 8.71
28.14
1 year 8.71
Extreme 8.71
28.14
3 years 3.69
Extreme 3.6855
46.5
5 years 3.69
Extreme 3.6855
77.92
10 years 3.69
Extreme 3.6855
465.75
Change 5-day change 1-year change 3-year change Capi.($)
-11.91%-21.37% - - 2.37B
+1.97%+2.03%+21.92%+0.55% 195B
+5.87%+5.27%-21.76%+27.59% 151B
+2.17%+0.89%-2.59%-16.62% 140B
+4.83%+2.06%-56.73%-15.23% 67.09B
+2.59%+3.95%+22.89%+3.75% 54.34B
+0.70%+3.44%-24.40%-28.67% 44.63B
+0.31%+1.30%+8.30%+42.29% 37.24B
-2.02%-3.91%+7.67%+9.36% 36.91B
+4.24%+4.66%-18.42%-3.15% 30.24B
Average +0.39%+2.74%-7.01%+2.21% 83.99B
Weighted average by Cap. +1.82%+3.44%-3.97%+2.21%

Financials

*1 *
Net sales - -
Net income - -
Net Debt - -
Logo ChronoScale Holdings Corporation
ChronoScale Corporation, formerly Ekso Bionics Holdings, Inc., designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. The Company operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. It assists people to perform challenging repetitive tasks for extended periods.
Employees
-
Date Price Change Volume
26-07-02 US$15.97 -11.91% 1,505
26-07-01 US$18.13 -16.61% 1,019
26-06-30 US$21.74 -4.69% 53
26-06-29 US$22.81 +12.31% 300